1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
- 2015
-
Mark
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.
(
- Contribution to journal › Article
- 2013
-
Mark
Late divergence of survival curves in cancer immunotherapy trials: interpretation and implications
(
- Contribution to journal › Article
-
Mark
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
(
- Contribution to journal › Article
- 2012
-
Mark
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors.
(
- Contribution to journal › Article
- 2011
-
Mark
Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer.
(
- Contribution to journal › Article
- 2009
-
Mark
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
(
- Contribution to journal › Article
-
Mark
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.
(
- Contribution to journal › Article
- 2000
-
Mark
Effects of transforming growth factor beta1 expression in a rat colon carcinoma : growth inhibition, leukocyte infiltration and production of interleukin-10 and tumor necrosis factor alpha
(
- Contribution to journal › Article
-
Mark
Immunohistochemical analysis of glioma-infiltrating leucocytes after peripheral therapeutic immunization with interferon-gamma-transfected glioma cells
(
- Contribution to journal › Article